BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21595610)

  • 41. Simian-human immunodeficiency virus-associated nephropathy in macaques.
    Stephens EB; Tian C; Dalton SB; Gattone VH
    AIDS Res Hum Retroviruses; 2000 Sep; 16(13):1295-306. PubMed ID: 10957726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral SIV, SHIV, and HIV type 1 infection.
    Ruprecht RM; Baba TW; Liska V; Ayehunie S; Andersen J; Montefiori DC; Trichel A; Murphey-Corb M; Martin L; Rizvi TA; Bernacky BJ; Buchl SJ; Keeling M
    AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S97-103. PubMed ID: 9581893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Live-attenuated lentivirus immunization modulates innate immunity and inflammation while protecting rhesus macaques from vaginal simian immunodeficiency virus challenge.
    Genescà M; Ma ZM; Wang Y; Assaf B; Qureshi H; Fritts L; Huang Y; McChesney MB; Miller CJ
    J Virol; 2012 Sep; 86(17):9188-200. PubMed ID: 22696662
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying
    Scinto HB; Gupta S; Thorat S; Mukhtar MM; Griffiths A; Delgado J; Plake E; Vyas HK; Strickland A; Byrareddy SN; Montefiori DC; LaBranche C; Pal R; Treece J; Orndorff S; Ferrari MG; Weiss D; Chenine AL; McLinden R; Michael N; Kim JH; Robb ML; Rerks-Ngarm S; Pitisuttithum P; Nitayaphan S; Ruprecht RM
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743361
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunization with recombinant HLA classes I and II, HIV-1 gp140, and SIV p27 elicits protection against heterologous SHIV infection in rhesus macaques.
    Mörner A; Jansson M; Bunnik EM; Schøller J; Vaughan R; Wang Y; Montefiori DC; Otting N; Bontrop R; Bergmeier LA; Singh M; Wyatt RT; Schuitemaker H; Biberfeld G; Thorstensson R; Lehner T
    J Virol; 2011 Jul; 85(13):6442-52. PubMed ID: 21490092
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-HIV and -SIV immunity in the vagina.
    Miller CJ; Lü FX
    Int Rev Immunol; 2003; 22(1):65-76. PubMed ID: 12710504
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.
    Lederman MM; Veazey RS; Offord R; Mosier DE; Dufour J; Mefford M; Piatak M; Lifson JD; Salkowitz JR; Rodriguez B; Blauvelt A; Hartley O
    Science; 2004 Oct; 306(5695):485-7. PubMed ID: 15486300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional MAIT Cells Are Associated With Reduced Simian-Human Immunodeficiency Virus Infection.
    Murugesan A; Ibegbu C; Styles TM; Jones AT; Shanmugasundaram U; Reddy PBJ; Rahman SJ; Saha P; Vijay-Kumar M; Shankar EM; Amara RR; Velu V
    Front Immunol; 2019; 10():3053. PubMed ID: 32010135
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How oestrogen or progesterone might change a woman's susceptibility to HIV-1 infection.
    Mingjia L; Short R
    Aust N Z J Obstet Gynaecol; 2002 Nov; 42(5):472-5. PubMed ID: 12495087
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of vaginal transmission of a simian human immunodeficiency virus (SHIV) encoding the reverse transcriptase gene from HIV-1 in Chinese rhesus macaques.
    Pal R; Nuttall J; Galmin L; Weiss D; Chung HK; Romano J
    Virology; 2009 Mar; 386(1):102-8. PubMed ID: 19195672
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of vaginal SHIV transmission in macaques by a coitally-dependent Truvada regimen.
    Radzio J; Aung W; Holder A; Martin A; Sweeney E; Mitchell J; Bachman S; Pau CP; Heneine W; García-Lerma JG
    PLoS One; 2012; 7(12):e50632. PubMed ID: 23226529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship of menstrual cycle and vaginal infection in female rhesus macaques challenged with repeated, low doses of SIVmac251.
    Morris MR; Byrareddy SN; Villinger F; Henning TC; Butler K; Ansari AA; McNicholl JM; Kersh EN
    J Med Primatol; 2015 Oct; 44(5):301-5. PubMed ID: 26054016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased susceptibility to vaginal simian/human immunodeficiency virus transmission in pig-tailed macaques coinfected with Chlamydia trachomatis and Trichomonas vaginalis.
    Henning TR; Butler K; Hanson D; Sturdevant G; Ellis S; Sweeney EM; Mitchell J; Deyounks F; Phillips C; Farshy C; Fakile Y; Papp J; Evan Secor W; Caldwell H; Patton D; McNicholl JM; Kersh E
    J Infect Dis; 2014 Oct; 210(8):1239-47. PubMed ID: 24755433
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studies.
    Gautam R; Nishimura Y; Lee WR; Donau O; Buckler-White A; Shingai M; Sadjadpour R; Schmidt SD; LaBranche CC; Keele BF; Montefiori D; Mascola JR; Martin MA
    J Virol; 2012 Aug; 86(16):8516-26. PubMed ID: 22647691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distribution of simian immunodeficiency virus target cells in vaginal tissues of normal rhesus macaques: implications for virus transmission.
    Poonia B; Wang X; Veazey RS
    J Reprod Immunol; 2006 Dec; 72(1-2):74-84. PubMed ID: 16956666
    [TBL] [Abstract][Full Text] [Related]  

  • 56. With minimal systemic T-cell expansion, CD8+ T Cells mediate protection of rhesus macaques immunized with attenuated simian-human immunodeficiency virus SHIV89.6 from vaginal challenge with simian immunodeficiency virus.
    Genescà M; Skinner PJ; Hong JJ; Li J; Lu D; McChesney MB; Miller CJ
    J Virol; 2008 Nov; 82(22):11181-96. PubMed ID: 18787003
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
    Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
    J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus.
    Miller CJ; Alexander NJ; Sutjipto S; Lackner AA; Gettie A; Hendrickx AG; Lowenstine LJ; Jennings M; Marx PA
    J Virol; 1989 Oct; 63(10):4277-84. PubMed ID: 2778875
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Animal model of mucosally transmitted human immunodeficiency virus type 1 disease: intravaginal and oral deposition of simian/human immunodeficiency virus in macaques results in systemic infection, elimination of CD4+ T cells, and AIDS.
    Joag SV; Adany I; Li Z; Foresman L; Pinson DM; Wang C; Stephens EB; Raghavan R; Narayan O
    J Virol; 1997 May; 71(5):4016-23. PubMed ID: 9094679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques.
    Jia M; Lu H; Markowitz M; Cheng-Mayer C; Wu X
    J Virol; 2016 Apr; 90(8):4017-4031. PubMed ID: 26842476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.